Farms.com Home   Ag Industry News

China offers tariff-free quotas on U.S. soybeans

China offers tariff-free quotas on U.S. soybeans

The quotas apply to about 10 million tonnes of American soybeans

By Diego Flammini
Staff Writer
Farms.com

A sizeable volume of U.S. soybeans will enter Chinese ports without tariffs.

China issued tariff-free quotas to processors to import U.S. soybeans. Public, private and international processors received the quotas, which apply to about 10 million tonnes (11 million tons) of soybeans, the Financial Post reported.

The quotas come about one week after Chinese and American officials met in Washington, D.C. for another round of trade talks. Following those discussions, President Trump told reporters China could buy up to US$50 billion of agricultural products annually once a trade deal is finalized.

This recent move by China should be viewed with optimism.

“The quotas work out to around 367 million bushels” of soybeans, Todd Hubbs, an agricultural economist from the University of Illinois, told Farms.com. “In a normal year without a trade war, China was importing about one billion bushels from the U.S. per year. So, this (amount) is quite a bit.”

Hubbs also categorized China’s decision as “strategic buying.”

Whenever the two countries seemed to make progress on a trade deal, China purchased U.S soybeans. But if trade talks took a different turn, they backed away, Hubbs said.

Soybean prices in general have experienced a recent upswing.

On Oct 1., November soybeans closed at US$9.19 per bushel and, as of early Tuesday afternoon, soybeans are trading around US$9.33 per bushel.

The possibility of a trade deal with China, paired with U.S. weather challenges, could bring the price up further, Hubbs said.

“I don’t think anyone has a good handle on what the winter storm in the Northern Plains did to the soybean crop,” he said. “The harvest losses could be quite high, but who knows. So, I think the strength in soybean prices is a combination of the trade deal and supply issues.”


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.